1 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 1, Not yet recruiting 1, Recruiting 1, Unknown 1 |
Follow Indapamide: new trials by email Literature Review of Indapamide trials Research Report on Indapamide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Use of Oral Indapamide to Reduce Disabiltiy Progression in Progressive Multiple Sclerosis (MS) Indapamide - Multiple Sclerosis | Phase 2 | Not yet recruiting | Eva M.M. Strijbis | 75 | 2026-09-01 | 2026-08-14 |
| Indapamide and Chlorthalidone to Reduce Urine Supersaturation for Kidney Stone Prevention Indapamide 2.5 MG, Hydrochlorothiazide 50Mg, Chlorthalidone 25mg - Kidney Stone | Phase 2 | Recruiting | Insel Gruppe AG, University Hospital Bern | 99 | 2024-10-01 | 2026-05-06 |
| Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2) Indapamide, Amlodipine, Olmesartan - Hypertension | Phase 2 | Completed | Alnylam Pharmaceuticals | 663 | 2021-11-05 | 2025-11-03 |
| Hydroxychloroquine and Indapamide in SPMS Hydroxychloroquine Pill, Indapamide Pill - Multiple Sclerosis, Secondary Progressive | Phase 2 | Unknown | University of Calgary | 35 | 2021-10-01 | 2022-05-18 |
Multiple Sclerosis, Chronic Progressive (2) · Hypertension (1) · Kidney Calculi (1) · Multiple Sclerosis (1) · Nephrolithiasis (1)
Alnylam Pharmaceuticals (1) · Eva M.M. Strijbis (1) · Insel Gruppe AG, University Hospital Bern (1) · University of Calgary (1)
Canada (2) · Estonia (1) · Germany (1) · Latvia (1) · Lithuania (1) · Poland (1) · Switzerland (1) · United Kingdom (1) · United States (1)